Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
Chowdhury F, Ali Syed K, Akter A, Rahman Bhuiyan T, Tauheed I, Khaton F, Biswas R, Ferdous J, Al Banna H, Ross AG, Mc Millan N, Sharma T, Kanchan V, Pal Singh A, Gill D, Lebens M, Nordqvist S, Holmgren J, Clemens JD, Qadri F. Chowdhury F, et al. Among authors: kanchan v. Vaccine. 2021 Jul 22;39(32):4450-4457. doi: 10.1016/j.vaccine.2021.06.069. Epub 2021 Jul 1. Vaccine. 2021. PMID: 34218960 Free article. Clinical Trial.
Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine.
Sharma T, Joshi N, Kumar Mandyal A, Nordqvist SL, Lebens M, Kanchan V, Löfstrand M, Jeverstam F, Mainul Ahasan M, Khan I, Karim M, Muktadir H, Muktadir A, Gill D, Holmgren J. Sharma T, et al. Among authors: kanchan v. Vaccine. 2020 Nov 25;38(50):7998-8009. doi: 10.1016/j.vaccine.2020.10.043. Epub 2020 Oct 31. Vaccine. 2020. PMID: 33139137 Free article.
A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants.
Kanchan V, Zaman K, Aziz AB, Zaman SF, Zaman F, Haque W, Khanam M, Karim MM, Kale S, Ali SK, Goveia MG, Kaplan SS, Gill D, Khan WA, Yunus M, Singh A, Clemens JD. Kanchan V, et al. Hum Vaccin Immunother. 2020 Mar 3;16(3):693-702. doi: 10.1080/21645515.2019.1664239. Epub 2019 Oct 29. Hum Vaccin Immunother. 2020. PMID: 31526218 Free PMC article. Clinical Trial.
Systems biology of vaccination for seasonal influenza in humans.
Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B. Nakaya HI, et al. Among authors: kanchan v. Nat Immunol. 2011 Jul 10;12(8):786-95. doi: 10.1038/ni.2067. Nat Immunol. 2011. PMID: 21743478 Free PMC article.
14 results